Differences in Dry Eye Symptoms Related to Geographic Location in Spain and Impact of Artificial Tears Use

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1033 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-01

Study Completion Date

2022-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study assessed the differences in DED symptomatology measured with the OSDI questionnaire regarding climate data of the geographic location in a large population in Spain, with a special focus on the relative humidity (RH) of the place of residence and the impact of artificial tears use, to help eye care practitioners in patient management and education

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sphenopalatine Ganglion Stimulation for Ocular and Oral Dryness

NCT05187533

Dry Eye Disease Xerostomia

COMPLETED NA

Correlation of Different Signs for Assessment of Dry Eye Syndrome

NCT01753687

Dry Eye Syndrome

COMPLETED NA

Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease

NCT01753596

Dry Eye Syndrome

WITHDRAWN PHASE3

Efficacy and Safety of Different Hyaluronic Acid Tear Substitutes Formulations in Evaporative Dry Eye

NCT06517667

Dry Eye

COMPLETED PHASE2/PHASE3

Impact of Tear Substitute Use on Dry Eye in Gamers.

NCT05536661

Evaporative Dry Eye

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This was a multicentre study enrolling patients to attend primary eye care centres of the EMO research group across 12 different Spanish locations. A comprehensive eye examination was performed in all participants. Dryness symptomatology was assessed with OSDI questionnaire. In subjects with dryness symptomatology (OSDI questionnaire score between 13 and 32) were prescribed to use high molecular weight HA-based artificial tears (DISOP Inc, Spain) along three months), instilled 3 times per day.

Additionally, the daily mean, minimum, and maximum values of the climate data for five different variables \[skin temperature (°C), wind gusts (m/s), air temperature (°C), atmospheric pressure (Pa) and RH (%)\] corresponding to the visit date were collected from the EU-funded Copernicus Climate Change Service and the 5-year average RH values published by the Spanish meteorological agency.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eye Syndromes Hyaluronic Acid OSDI

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

high molecular weight HA-based artificial tears

use of high molecular weight HA-based artificial tears three times per day

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Volunteer subjects of legal age will be included who agree to participate in the study after being informed by the researcher of each center

Exclusion Criteria

* Hyperthyroidis
* Rheumatism
* Lupus
* Autoimmune disease
* Previous diagnosis of Dye Eye Disease
* Cicatricial conjunctivitis
* Pterygium
* Eyelid trichiasis
* History of any eye medication use in the last 3 months to treat any eye condition (glaucoma, etc.)
* Active anterior eye inflammation (such as blepharitis, conjunctivitis, keratitis, scleritis, uveitis, etc.)
* Use of contact lenses in the last 3 months
* Previous ocular trauma or surgery in the last 6 months.

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes